Correspondence 0001493152-25-006552 from Kraig Biocraft Laboratories, Inc (KBLB) (CIK 0001413119) (KBLB)
Kraig Biocraft Laboratories, Inc (KBLB) (CIK 0001413119)
Date: Feb. 14, 2025 · CIK: 0001413119 · Accession: 0001493152-25-006552
AI Filing Summary & Sentiment
File numbers found in text: 333-284773
Show Raw Text
CORRESP
1
filename1.htm
Kraig
Biocraft Laboratories, Inc.
2723
South State St. Suite 150
Ann
Arbor, Michigan 48104
February
14, 2025
Via
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
Office
of Industrial Applications and Services
100
F Street, NE
Washington,
D.C., 20549
Re:
Kraig
Biocraft Laboratories, Inc.
Registration
Statement on Form S-1 (File No. 333-284773)
Request
for Acceleration of Effectiveness
Ladies
and Gentlemen:
In
accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Kraig Biocraft Laboratories,
Inc. hereby requests that the effectiveness of the above-referenced Registration Statement on Form S-1 (the “Registration Statement”)
be accelerated and that the Registration Statement become effective at 5:00 p.m., Eastern Time, on Friday, February 14,
2025, or as soon thereafter as practicable.
Very
truly yours,
Kraig
Biocraft Laboratories, Inc.
By:
/s/
Jon Rice
Name:
Jon
Rice
Title:
Chief
Executive Officer
cc:
Louis
Taubman, Esq.
Hunter
Taubman Fischer & Li LLC